Indapamide, Telmisartan

YLPIO 80 mg/2,5 mg tabletten

TabletNetherlandsAuthorisedAuthorised 28 Jul 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Tolurindo 40 mg/1,5 mg tablete s prilagođenim oslobađanjemCroatia · Tableta s prilagođenim oslobađanjem · Krka - farma d.o.o., Radnička cesta 48, Zagreb, HrvatskaSame form
Tolurindo 80 mg/1,5 mg tablete s prilagođenim oslobađanjemCroatia · Tableta s prilagođenim oslobađanjem · Krka - farma d.o.o., Radnička cesta 48, Zagreb, HrvatskaSame form
Tolurindo®Serbia · 40mg+1.5mg · tableta sa modifikovanim oslobađanjem · Krka-Farma D.O.O. BeogradSame form
Tolurindo®Serbia · 80mg+1.5mg · tableta sa modifikovanim oslobađanjem · Krka-Farma D.O.O. BeogradSame form

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Indapamide, Telmisartan

YLPIO 80 mg/2,5 mg tabletten

TabletNetherlandsAuthorisedAuthorised 28 Jul 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Summary of product characteristics

CBG-MEB

Package leafletCBG-MEB

Register entryCBG-MEB

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Indapamide, Telmisartan
Dosage form: Tablet
Route: Oraal gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 28 Jul 2025
Registration: 132781
Marketing authorisation holder: PRO.MED.CS Praha a.s.
ATC code: C09DA07
Group: Cardiovascular system
Procedure: National (RVG)
Supply: Uitsluitend recept